Metformin is superior to intermittent IIT for preservation of beta-cell function and better glycemic control in early Type-2 diabetes patients.
CARDIA Study: Lactation Duration Inversely Associated with Diabetes Progression in Women across the Childbearing Years
The CARDIA study with a 30-year follow-up demonstrated an inverse association between lactation duration and progression of diabetes in women.
Combination therapy of vildagliptin/metformin demonstrated consistent HbA1c reduction across wide spectrum of drug naïve Asian T2DM patients.
The CANVAS Program demonstrates that canagliflozin reduces the risk of CV events in type-2 diabetes patients who are at high risk of CVD.